ITRM20040288A1 - Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. - Google Patents

Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.

Info

Publication number
ITRM20040288A1
ITRM20040288A1 IT000288A ITRM20040288A ITRM20040288A1 IT RM20040288 A1 ITRM20040288 A1 IT RM20040288A1 IT 000288 A IT000288 A IT 000288A IT RM20040288 A ITRM20040288 A IT RM20040288A IT RM20040288 A1 ITRM20040288 A1 IT RM20040288A1
Authority
IT
Italy
Prior art keywords
neoplasies
butoxyiminomethyl
camptotecin
uterus
medication
Prior art date
Application number
IT000288A
Other languages
English (en)
Italian (it)
Inventor
Paolo Carminati
Franco Cavalli
Marco Corsi
Luca Gianni
Cristiana Sessa
Claudio Zanna
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000288A priority Critical patent/ITRM20040288A1/it
Publication of ITRM20040288A1 publication Critical patent/ITRM20040288A1/it
Priority to TW094116349A priority patent/TWI351283B/zh
Priority to PL05761294T priority patent/PL1773451T3/pl
Priority to PT05761294T priority patent/PT1773451E/pt
Priority to MXPA06014162A priority patent/MXPA06014162A/es
Priority to CN201410616189.7A priority patent/CN104352496A/zh
Priority to EP05761294A priority patent/EP1773451B1/en
Priority to CNA2005800157280A priority patent/CN1953784A/zh
Priority to KR1020067027912A priority patent/KR101221640B1/ko
Priority to ES05761294T priority patent/ES2372056T3/es
Priority to AU2005251573A priority patent/AU2005251573B2/en
Priority to HR20110718T priority patent/HRP20110718T1/hr
Priority to DK05761294.7T priority patent/DK1773451T3/da
Priority to SI200531393T priority patent/SI1773451T1/sl
Priority to US11/628,458 priority patent/US7700613B2/en
Priority to RS20110434A priority patent/RS52038B/sr
Priority to JP2007526712A priority patent/JP2008501785A/ja
Priority to CA2565213A priority patent/CA2565213C/en
Priority to BRPI0511931-6A priority patent/BRPI0511931A/pt
Priority to AT05761294T priority patent/ATE521351T1/de
Priority to PCT/IT2005/000320 priority patent/WO2005120643A2/en
Priority to ARP050102379A priority patent/AR049220A1/es
Priority to CY20111101092T priority patent/CY1112032T1/el
Priority to JP2014165542A priority patent/JP2014231518A/ja
Priority to HK15106661.8A priority patent/HK1205951A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT000288A 2004-06-11 2004-06-11 Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. ITRM20040288A1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT000288A ITRM20040288A1 (it) 2004-06-11 2004-06-11 Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
TW094116349A TWI351283B (en) 2004-06-11 2005-05-19 Use of 7-t-butoxyiminomethylcamptothecin for the p
PCT/IT2005/000320 WO2005120643A2 (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
AU2005251573A AU2005251573B2 (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
SI200531393T SI1773451T1 (sl) 2004-06-11 2005-06-08 Uporaba 7-t-butoksiiminometilkamptotecina za zdravljenje uterinih neoplazem
MXPA06014162A MXPA06014162A (es) 2004-06-11 2005-06-08 Uso de 7-t-butoximinometilcamptotecina para tratar neoplasmas uterinos.
CN201410616189.7A CN104352496A (zh) 2004-06-11 2005-06-08 7-叔丁氧亚氨基甲基喜树碱用于治疗子宫肿瘤的用途
EP05761294A EP1773451B1 (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
CNA2005800157280A CN1953784A (zh) 2004-06-11 2005-06-08 7－叔丁氧亚氨基甲基喜树碱用于治疗子宫肿瘤的用途
KR1020067027912A KR101221640B1 (ko) 2004-06-11 2005-06-08 자궁 종양 치료용 약제의 제조를 위한7-티-부톡시이미노메틸캄토테신의 용도
ES05761294T ES2372056T3 (es) 2004-06-11 2005-06-08 Uso de 7-t-butoxiiminometilcamptotecina para tratar neoplasmas uterinos.
PL05761294T PL1773451T3 (pl) 2004-06-11 2005-06-08 Zastosowanie 7-t-butoksyiminometylokamptotecyny do leczenia nowotworów macicy
HR20110718T HRP20110718T1 (hr) 2004-06-11 2005-06-08 UPOTREBA 7-t-BUTOKSIIMINOMETILKAMPTOTECINA U LIJEČENJU NOVOTVORINA MATERNICE
DK05761294.7T DK1773451T3 (da) 2004-06-11 2005-06-08 Anvendelse af 7-t-butoxyiminomethylcamptothecin til behandling af uterine neoplasmer
PT05761294T PT1773451E (pt) 2004-06-11 2005-06-08 Uso de 7-t-butoxiiminometilcamptotecina para o tratamento de neoplasias uterinas
US11/628,458 US7700613B2 (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
RS20110434A RS52038B (sr) 2004-06-11 2005-06-08 Upotreba 7-butoksiiminometilkamptotecina za lečenje neoplazmi materice
JP2007526712A JP2008501785A (ja) 2004-06-11 2005-06-08 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用
CA2565213A CA2565213C (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
BRPI0511931-6A BRPI0511931A (pt) 2004-06-11 2005-06-08 uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos
AT05761294T ATE521351T1 (de) 2004-06-11 2005-06-08 Verwendung von 7-t-butoxyiminomethylcamptothecin zur behandlung von gebärmuttertumoren
ARP050102379A AR049220A1 (es) 2004-06-11 2005-06-13 Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos
CY20111101092T CY1112032T1 (el) 2004-06-11 2011-11-14 Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας
JP2014165542A JP2014231518A (ja) 2004-06-11 2014-08-15 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用
HK15106661.8A HK1205951A1 (en) 2004-06-11 2015-07-13 Use of 7-t-butoxyiminomethylcamptothecin for the prepartion of a medicament for the treatment of uterine neoplasms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000288A ITRM20040288A1 (it) 2004-06-11 2004-06-11 Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.

Publications (1)

Publication Number Publication Date
ITRM20040288A1 true ITRM20040288A1 (it) 2004-09-11

Family

ID=34979678

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000288A ITRM20040288A1 (it) 2004-06-11 2004-06-11 Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.

Country Status (23)

Country Link
US (1) US7700613B2 (enExample)
EP (1) EP1773451B1 (enExample)
JP (2) JP2008501785A (enExample)
KR (1) KR101221640B1 (enExample)
CN (2) CN1953784A (enExample)
AR (1) AR049220A1 (enExample)
AT (1) ATE521351T1 (enExample)
AU (1) AU2005251573B2 (enExample)
BR (1) BRPI0511931A (enExample)
CA (1) CA2565213C (enExample)
CY (1) CY1112032T1 (enExample)
DK (1) DK1773451T3 (enExample)
ES (1) ES2372056T3 (enExample)
HK (1) HK1205951A1 (enExample)
HR (1) HRP20110718T1 (enExample)
IT (1) ITRM20040288A1 (enExample)
MX (1) MXPA06014162A (enExample)
PL (1) PL1773451T3 (enExample)
PT (1) PT1773451E (enExample)
RS (1) RS52038B (enExample)
SI (1) SI1773451T1 (enExample)
TW (1) TWI351283B (enExample)
WO (1) WO2005120643A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213385A1 (en) * 2005-08-10 2008-09-04 Oskar Kalb Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin
AU2008210511A1 (en) * 2007-02-01 2008-08-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pharmaceutical composition comprising a campothecin derivative

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
DE69635560T2 (de) * 1995-06-21 2006-08-17 Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) Camptothecinanaloge, Verfahren zur ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
UA57757C2 (uk) * 1996-12-20 2003-07-15 Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
DK1044977T3 (da) 1999-03-09 2002-07-08 Sigma Tau Ind Farmaceuti Camptothecinderivater med antitumoraktivitet
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
WO2003043584A2 (en) 2001-11-20 2003-05-30 University Of Kentucky Research Foundation Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins
WO2004103358A2 (en) * 2003-05-21 2004-12-02 Novartis Ag Combination of histone deacetylase inhibitors with chemotherapeutic agents

Also Published As

Publication number Publication date
TWI351283B (en) 2011-11-01
CN1953784A (zh) 2007-04-25
SI1773451T1 (sl) 2012-01-31
JP2008501785A (ja) 2008-01-24
ES2372056T3 (es) 2012-01-13
WO2005120643A8 (en) 2006-12-14
BRPI0511931A (pt) 2008-01-22
CA2565213C (en) 2012-08-07
CA2565213A1 (en) 2005-12-22
AU2005251573B2 (en) 2010-04-15
CY1112032T1 (el) 2015-11-04
PT1773451E (pt) 2011-11-02
JP2014231518A (ja) 2014-12-11
AR049220A1 (es) 2006-07-05
WO2005120643A3 (en) 2006-03-30
CN104352496A (zh) 2015-02-18
AU2005251573A1 (en) 2005-12-22
US7700613B2 (en) 2010-04-20
DK1773451T3 (da) 2011-11-28
KR101221640B1 (ko) 2013-01-14
WO2005120643A2 (en) 2005-12-22
MXPA06014162A (es) 2007-03-07
EP1773451A2 (en) 2007-04-18
EP1773451B1 (en) 2011-08-24
US20080020030A1 (en) 2008-01-24
RS52038B (sr) 2012-04-30
HRP20110718T1 (hr) 2011-12-31
KR20070030246A (ko) 2007-03-15
TW200605891A (en) 2006-02-16
ATE521351T1 (de) 2011-09-15
HK1205951A1 (en) 2015-12-31
PL1773451T3 (pl) 2012-01-31

Similar Documents

Publication Publication Date Title
EP1477403A4 (en) MEDICINES SUPPLY
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
DE50212546D1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
DE60209145D1 (de) Pharmazeutische formulierungen mit platinderivaten
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20033143D0 (no) Farmasoytisk preparat
NO20033815L (no) Farmasöytiske salter
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
DE60103512D1 (de) Pharmazeutische zusammensetzung enthaltend pemetrexed zusammen mit monothioglycerol, l-cystein oder thioglykolsäure
NO20025805L (no) Farmasöytisk preparat
ATE348599T1 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
ITRM20020562A1 (it) Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
DE60331041D1 (de) Orale dosierform für die kontrollierte arzneimittelfreisetzung
FR2820311B3 (fr) Distributeur de medicament portatif
ITMI20032523A1 (it) Forma di dosaggio per uso orale comprendente un farmaco
ITRM20020492A1 (it) Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
ITRM20010293A0 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20060584A1 (it) Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
ITRM20040329A1 (it) Procedimento per la preparazione di un liofilizzato di muscari comosum da utilizzarsi in una composizione farmaceutica per il trattamento della stipsi.
ITRM20020511A1 (it) Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.
ITRM20010319A1 (it) Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia.